XML 48 R40.htm IDEA: XBRL DOCUMENT
v3.22.2

Derivatives (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of derivative financial instruments on consolidated balance sheet | The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the consolidated balance sheets as of June 30, 2022 and December 31, 2021 ($ in thousands):(1)
​ | ​ | ​ | ​ | ​ | ​
​ |  | Derivative Liabilities
​ | ​ | Balance Sheet | ​ | Fair
As of June 30, 2022 |  | Location |  | Value
Derivatives Designated in Hedging Relationships | ​ | ​ | ​ | ​ | ​
Interest rate swaps |  | Liabilities associated with real estate held for sale and classified as discontinued operations | ​ | $ | —
Total |  |  | ​ | $ | —
​ | ​ | ​ | ​ | ​ | ​
As of December 31, 2021 |  |  | ​ |  |
Derivatives Designated in Hedging Relationships |  |  | ​ |  |
Interest rate swaps |  | Liabilities associated with real estate held for sale and classified as discontinued operations | ​ | $ | 8,395
Total |  |  | ​ | $ | 8,395
(1) | Over the next 12 months, the Company expects that $2.4 million related to its proportionate share of cash flow hedges held by SAFE will be reclassified from “Accumulated other comprehensive income (loss)” as a decrease to earnings from equity method investments.
Schedule of derivative financial instruments on consolidated statements of operations and comprehensive income | The table below presents the effect of the Company’s derivative financial instruments, including the Company’s share of derivative financial instruments at certain of its equity method investments, in the consolidated statements of operations and the consolidated statements of comprehensive income (loss) ($ in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Amount of Gain |  | Amount of Gain
​ | ​ | Location of Gain | ​ | (Loss) Recognized in | ​ | (Loss) Reclassified
​ | ​ | (Loss) | ​ | Accumulated Other | ​ | from Accumulated
Derivatives Designated in | ​ | When Recognized in | ​ | Comprehensive | ​ | Other Comprehensive
Hedging Relationships |  | Income |  | Income |  | Income into Earnings
For the Three Months Ended June 30, 2022 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest rate swaps |  | Earnings from equity method investments | ​ | $ | 4,382 | ​ | $ | (580)
For the Three Months Ended June 30, 2021 |  |  | ​ |  |  | ​ |  |
Interest rate swaps |  | Net income from discontinued operations | ​ | $ | (764) | ​ | $ | (2,029)
Interest rate swaps |  | Earnings from equity method investments | ​ |  | — | ​ |  | (457)
For the Six Months Ended June 30, 2022 | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Interest rate swaps |  | Earnings from equity method investments | ​ | $ | 7,138 | ​ | $ | (1,201)
For the Six Months Ended June 30, 2021 |  |  | ​ |  |  | ​ |  |
Interest rate swaps |  | Net income from discontinued operations | ​ | $ | 2,573 | ​ | $ | (4,133)
Interest rate swaps |  | Earnings from equity method investments | ​ |  | 8,638 | ​ |  | (691)

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration